Cookies

We'd like to use optional analytics cookies to understand site usage and improve AcquireEU. You can accept or reject them. See our Privacy Notice.

← Browse/CARDIAGS

CARDIAGS

🔴 Liquidation🇫🇷 France📍 Auvergne-Rhône-Alpes🏭 Healthcare & Life Sciences
Company Overview

Jugement prononçant la liquidation judiciaire désignant liquidateur la Selarl Mj Synergie Représentée par Maître Bruno Walczak, Maître Michaël Elancry Ou Maître Etienne André 136 cours Lafayette Cs 33434 69441 Lyon CEDEX 03, et mettant fin à la mission de l'administrateur la Selarl Fhbx Représentée par Maître Gaël Couturier Ou Maître Charlotte Fort 24 rue Childebert 69002 Lyon.

Financial Profile
Employees
Not disclosed
Revenue Range
Not disclosed
Insolvency Details
Country & Jurisdiction
🇫🇷 France
Region
Auvergne-Rhône-Alpes
Sector
Healthcare & Life Sciences
Insolvency Stage
🔴 Liquidation
Date Filed
17 May 2026
National Register ID
798465589
Case Reference
798465589
🔗 View original filing (bodacc-datadila.opendatasoft.com)
Associated Assets & Estate Scope

In Liquidation proceedings, the practitioner assesses and liquidates both tangible and intangible assets. Prospective acquirers can bid on the entire operating business or submit carve-out offers for specific asset classes:

⚙️ Plant & Equipment
Specialized tools, production machinery, vehicles
🏢 Property & Leases
Industrial premises, leasehold rights, regional depots
🏷️ Brand, IP & Data
Trademarks, domains, customer lists, order books
📦 Inventory & Stock
Finished goods, raw materials, supplier terms
Official asset inventory schedules are provided by the practitioner upon NDA signature.Check filing for creditor reports →
Proceedings Timeline
17 May 2026
Filing date
Active
Liquidation underway — assets being assessed for sale
Physical Asset & Real Estate Recovery

Looking for seized equipment, plant machinery, or real estate in France?

CARDIAGS and other distressed entities often have commercial property, production lines, and vehicle fleets being liquidated through official judicial auctions at 30–70% below market value.